Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 4Osteoporosis 3Prostatic Neoplasms 2Pain 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Myocardial Ischemia 1Multiple Myeloma 1Lymphoma 1Lung Neoplasms 1Leukemia 1Heart Diseases 1Disease Progression 1Coronary Disease 1Colorectal Neoplasms 1Colonic Neoplasms 1Cardiovascular Diseases 1Carcinoma, Non-Small-Cell Lung 1Bone Diseases, Metabolic 1Bone Diseases 1

Interventions

Vitamin D 2Cholecalciferol 2Aspirin 2Vorinostat 1Vitamin E 1Raloxifene Hydrochloride 1Progestins 1Hormone Replacement Therapy 1Fish Oils 1Fatty Acids, Omega-3 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Bortezomib 1Antioxidants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Cardiovascular Diseases × Calcium × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡